DeborahManstMDMPH
Preventive Medicine • Chicago, ILPublic Health & General Preventive Medicine
Oncogeneralist/Family Medicine
Dr. Manst is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1220 S Wood St
Chicago, IL 60608Phone+1 312-996-2000Fax+1 909-206-0540
Summary
- Deborah Manst, MD is a preventive medicine specialist based in Chicago, Illinois with subspecialties in cancer prevention, risk, survivorship, and genetics. She completed her education and residencies at Loyola University Chicago Stritch School of Medicine, Cook County Health and Hospitals System/Northwestern Feinberg School of Medicine, and University of Arizona College of Medicine-Phoenix, and has conducted a fellowship in cancer survivorship at University of Illinois College of Medicine at Chicago. Her experience includes cancer genetics and cancer prevention/survivorship. Dr. Manst also has multiple publications under her belt, including work on gene mutation and its role in cancer survivorship and a study on thromboembolic events in patients with systemic lupus erythematosus.
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Cancer Survivorship, 2019 - 2020
Cook County Health and Hospitals System/Northwestern Feinberg School of MedicineResidency, Public Health and General Preventive Medicine, 2017 - 2019
Loyola University ChicagoMPH, Public Health, Cum Laude, 2015 - 2017
University of Arizona College of Medicine-PhoenixResidency, Surgery, 2012 - 2014
Loyola University Chicago Stritch School of MedicineClass of 2012
Certifications & Licensure
IL State Medical License 2017 - 2026- American Board of Preventive Medicine Public Health & General Preventive Medicine
Publications & Presentations
PubMed
- 42 citationsIgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus ErythematosusNadera J. Sweiss, Ronghai Bo, Reena Kapadia, Deborah Manst, Farzan Mahmood
Plos One. 2010-08-19
Journal Articles
- The Challenging PMS2 Gene Mutation and its Role in Cancer SurvivorshipDeborah J. Manst , MD, MPH and Susan Hong, MD, MPH, International Journal of Clinical Studies & Medical Case Reports, 7/8/2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
